Literature DB >> 27221072

Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lens.

Marco Cattalini1, Martina Soliani1, Giuseppe Lopalco2, Donato Rigante3, Luca Cantarini4,5.   

Abstract

Monogenic autoinflammatory disorders (AIDs) are rare diseases driven by cytokine-mediated extraordinary sterile inflammation that results from the activation of innate immune pathways. The clinical hallmark of these diseases is the recurrence of stereotyped episodes of systemic- and organ-specific inflammation; the most common systems involved being the skin, musculoskeletal system, gastrointestinal tract, and central nervous system. The autoinflammatory disorders may have a profound impact on the quality of life of the affected patients, and a delayed diagnosis may lead to severe complications, the most dreadful of which is AA-Amyloidosis. This review gives an overview on the four main AIDs, namely familial Mediterranean fever, tumor necrosis factor receptor-associated periodic syndrome, cryopyrinopathies, and mevalonate kinase deficiency, focusing on their clinical phenotype in adults and differential diagnosis, suggesting a diagnostic algorithm, and reviewing the available treatments.

Entities:  

Keywords:  Anakinra; Autoinflammatory disorders; Canakinumab; Hereditary periodic fever syndromes

Mesh:

Year:  2016        PMID: 27221072     DOI: 10.1007/s11739-016-1466-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  81 in total

1.  Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers.

Authors:  Luca Cantarini; Antonio Vitale; Beatrice Bartolomei; Mauro Galeazzi; Donato Rigante
Journal:  Clin Exp Rheumatol       Date:  2012-04-13       Impact factor: 4.473

2.  Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study.

Authors:  Ariel C Bulua; Douglas B Mogul; Ivona Aksentijevich; Harjot Singh; David Y He; Larry R Muenz; Michael M Ward; Cheryl H Yarboro; Daniel L Kastner; Richard M Siegel; Keith M Hull
Journal:  Arthritis Rheum       Date:  2012-03

3.  A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome.

Authors:  Raphaela Goldbach-Mansky; Sharukh D Shroff; Mildred Wilson; Christopher Snyder; Sara Plehn; Beverly Barham; Tuyet-Hang Pham; Frank Pucino; Robert A Wesley; Joanne H Papadopoulos; Steven P Weinstein; Scott J Mellis; Daniel L Kastner
Journal:  Arthritis Rheum       Date:  2008-08

Review 4.  The protean visage of systemic autoinflammatory syndromes: a challenge for inter-professional collaboration.

Authors:  D Rigante
Journal:  Eur Rev Med Pharmacol Sci       Date:  2010-01       Impact factor: 3.507

5.  Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.

Authors:  Sule Apras Bilgen; Levent Kilic; Ali Akdogan; Sedat Kiraz; Umut Kalyoncu; Omer Karadag; Ihsan Ertenli; Ismail Dogan; Meral Calguneri
Journal:  J Clin Rheumatol       Date:  2011-10       Impact factor: 3.517

Review 6.  Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes.

Authors:  Anna Simon; Jos W M van der Meer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-24       Impact factor: 3.619

7.  Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders.

Authors:  L Cantarini; O M Lucherini; F Iacoponi; R Cimaz; G Simonini; D Rigante; F Laghi Pasini; C T Baldari; P L Capecchi; M G Brizi; M Galeazzi
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Oct-Dec       Impact factor: 3.219

8.  The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.

Authors:  Catherine Dodé; Marc André; Thierry Bienvenu; Pierre Hausfater; Christophe Pêcheux; Jacques Bienvenu; Jean-Claude Lecron; Philippe Reinert; Daniel Cattan; Jean-Charles Piette; Marie-France Szajnert; Marc Delpech; Gilles Grateau
Journal:  Arthritis Rheum       Date:  2002-08

9.  Use of canakinumab in the cryopyrin-associated periodic syndrome.

Authors:  Helen J Lachmann; Isabelle Kone-Paut; Jasmin B Kuemmerle-Deschner; Kieron S Leslie; Eric Hachulla; Pierre Quartier; Xavier Gitton; Albert Widmer; Neha Patel; Philip N Hawkins
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

10.  Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome.

Authors:  Kazuki Takada; Ivona Aksentijevich; Vijayabhanu Mahadevan; Jane A Dean; Richard I Kelley; Daniel L Kastner
Journal:  Arthritis Rheum       Date:  2003-09
View more
  7 in total

1.  The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy.

Authors:  Antonio Vitale; Donato Rigante; Orso Maria Lucherini; Anna De Palma; Ida Orlando; Stefano Gentileschi; Jurgen Sota; Antonella Simpatico; Claudia Fabiani; Mauro Galeazzi; Bruno Frediani; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2017-02-13       Impact factor: 3.397

2.  Tumor necrosis factor inhibitors in tumor necrosis factor receptor-associated periodic syndrome: still a chance to work?

Authors:  Donato Rigante
Journal:  Intern Emerg Med       Date:  2016-11-05       Impact factor: 3.397

Review 3.  Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.

Authors:  Antonio Brucato; Giacomo Emmi; Luca Cantarini; Andrea Di Lenarda; Marco Gattorno; Giuseppe Lopalco; Renzo Marcolongo; Massimo Imazio; Alberto Martini; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-04-09       Impact factor: 3.397

Review 4.  Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Authors:  Alessandra Bettiol; Giuseppe Lopalco; Giacomo Emmi; Luca Cantarini; Maria Letizia Urban; Antonio Vitale; Nunzio Denora; Antonio Lopalco; Annalisa Cutrignelli; Angela Lopedota; Vincenzo Venerito; Marco Fornaro; Alfredo Vannacci; Donato Rigante; Rolando Cimaz; Florenzo Iannone
Journal:  Int J Mol Sci       Date:  2019-04-17       Impact factor: 5.923

Review 5.  Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases.

Authors:  Carla Gaggiano; Donato Rigante; Antonio Vitale; Orso Maria Lucherini; Alessandra Fabbiani; Giovanna Capozio; Chiara Marzo; Viviana Gelardi; Salvatore Grosso; Bruno Frediani; Alessandra Renieri; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2019-12-31       Impact factor: 4.711

Review 6.  IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives.

Authors:  Hana Malcova; Zuzana Strizova; Tomas Milota; Ilja Striz; Anna Sediva; Dita Cebecauerova; Rudolf Horvath
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

Review 7.  Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.

Authors:  Alessandra Soriano; Marco Soriano; Gerard Espinosa; Raffaele Manna; Giacomo Emmi; Luca Cantarini; José Hernández-Rodríguez
Journal:  Front Immunol       Date:  2020-06-03       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.